Cargando…

User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing

Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of understanding about how self-administered tests are used by the general public for mass testing in different...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Min, Bond, Raymond, Robertson, Louise J., Moore, Julie, Kowalczyk, Amanda, Price, Ruth, Burns, William, Nesbit, M. Andrew, McLaughlin, James, Moore, Tara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263628/
https://www.ncbi.nlm.nih.gov/pubmed/34234188
http://dx.doi.org/10.1038/s41598-021-93262-0
_version_ 1783719425632894976
author Jing, Min
Bond, Raymond
Robertson, Louise J.
Moore, Julie
Kowalczyk, Amanda
Price, Ruth
Burns, William
Nesbit, M. Andrew
McLaughlin, James
Moore, Tara
author_facet Jing, Min
Bond, Raymond
Robertson, Louise J.
Moore, Julie
Kowalczyk, Amanda
Price, Ruth
Burns, William
Nesbit, M. Andrew
McLaughlin, James
Moore, Tara
author_sort Jing, Min
collection PubMed
description Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of understanding about how self-administered tests are used by the general public for mass testing in different environmental settings. The purpose of this study was to assess the user experience (UX) (including usability) of a self-testing kit to identify COVID-19 antibodies used by a representative sample of the public in their cars, which included 1544 participants in Northern Ireland. The results based on 5-point Likert ratings from a post-test questionnaire achieved an average UX score of 96.03% [95% confidence interval (CI) 95.05–97.01%], suggesting a good degree of user experience. The results of the Wilcoxon rank sum tests suggest that UX scores were independent of the user’s age and education level although the confidence in this conclusion could be strengthened by including more participants aged younger than 18 and those with only primary or secondary education. The agreement between the test result as interpreted by the participant and the researcher was 95.85% [95% CI 94.85–96.85%], Kappa score 0.75 [95% CI 0.69–0.81] (indicating substantial agreement). Text analysis via the latent Dirichlet allocation model for the free text responses in the survey suggest that the user experience could be improved for blood-sample collection, by modifying the method of sample transfer to the test device and giving clearer instructions on how to interpret the test results. The overall findings provide an insight into the opportunities for improving the design of SARS-CoV-2 antibody testing kits to be used by the general public and therefore inform protocols for future user experience studies of point-of-care tests.
format Online
Article
Text
id pubmed-8263628
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82636282021-07-09 User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing Jing, Min Bond, Raymond Robertson, Louise J. Moore, Julie Kowalczyk, Amanda Price, Ruth Burns, William Nesbit, M. Andrew McLaughlin, James Moore, Tara Sci Rep Article Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of understanding about how self-administered tests are used by the general public for mass testing in different environmental settings. The purpose of this study was to assess the user experience (UX) (including usability) of a self-testing kit to identify COVID-19 antibodies used by a representative sample of the public in their cars, which included 1544 participants in Northern Ireland. The results based on 5-point Likert ratings from a post-test questionnaire achieved an average UX score of 96.03% [95% confidence interval (CI) 95.05–97.01%], suggesting a good degree of user experience. The results of the Wilcoxon rank sum tests suggest that UX scores were independent of the user’s age and education level although the confidence in this conclusion could be strengthened by including more participants aged younger than 18 and those with only primary or secondary education. The agreement between the test result as interpreted by the participant and the researcher was 95.85% [95% CI 94.85–96.85%], Kappa score 0.75 [95% CI 0.69–0.81] (indicating substantial agreement). Text analysis via the latent Dirichlet allocation model for the free text responses in the survey suggest that the user experience could be improved for blood-sample collection, by modifying the method of sample transfer to the test device and giving clearer instructions on how to interpret the test results. The overall findings provide an insight into the opportunities for improving the design of SARS-CoV-2 antibody testing kits to be used by the general public and therefore inform protocols for future user experience studies of point-of-care tests. Nature Publishing Group UK 2021-07-07 /pmc/articles/PMC8263628/ /pubmed/34234188 http://dx.doi.org/10.1038/s41598-021-93262-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Jing, Min
Bond, Raymond
Robertson, Louise J.
Moore, Julie
Kowalczyk, Amanda
Price, Ruth
Burns, William
Nesbit, M. Andrew
McLaughlin, James
Moore, Tara
User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing
title User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing
title_full User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing
title_fullStr User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing
title_full_unstemmed User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing
title_short User experience analysis of AbC-19 Rapid Test via lateral flow immunoassays for self-administrated SARS-CoV-2 antibody testing
title_sort user experience analysis of abc-19 rapid test via lateral flow immunoassays for self-administrated sars-cov-2 antibody testing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263628/
https://www.ncbi.nlm.nih.gov/pubmed/34234188
http://dx.doi.org/10.1038/s41598-021-93262-0
work_keys_str_mv AT jingmin userexperienceanalysisofabc19rapidtestvialateralflowimmunoassaysforselfadministratedsarscov2antibodytesting
AT bondraymond userexperienceanalysisofabc19rapidtestvialateralflowimmunoassaysforselfadministratedsarscov2antibodytesting
AT robertsonlouisej userexperienceanalysisofabc19rapidtestvialateralflowimmunoassaysforselfadministratedsarscov2antibodytesting
AT moorejulie userexperienceanalysisofabc19rapidtestvialateralflowimmunoassaysforselfadministratedsarscov2antibodytesting
AT kowalczykamanda userexperienceanalysisofabc19rapidtestvialateralflowimmunoassaysforselfadministratedsarscov2antibodytesting
AT priceruth userexperienceanalysisofabc19rapidtestvialateralflowimmunoassaysforselfadministratedsarscov2antibodytesting
AT burnswilliam userexperienceanalysisofabc19rapidtestvialateralflowimmunoassaysforselfadministratedsarscov2antibodytesting
AT nesbitmandrew userexperienceanalysisofabc19rapidtestvialateralflowimmunoassaysforselfadministratedsarscov2antibodytesting
AT mclaughlinjames userexperienceanalysisofabc19rapidtestvialateralflowimmunoassaysforselfadministratedsarscov2antibodytesting
AT mooretara userexperienceanalysisofabc19rapidtestvialateralflowimmunoassaysforselfadministratedsarscov2antibodytesting